Krishnaprasad Baby

Cited by

	All	Since 2019
Citations	177	176
h-index	6	6
i10-index	3	3

20182019202020212022202320241 5 45 65 48 12

Public access

View all

4 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Yogendra NayakAssociate Professor, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher EducationVerified email at manipal.edu
Usha Y NayakProfessor of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of HigherVerified email at manipal.edu
Chetan MehtaResearch Scholar, Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, ManipalVerified email at learner.manipal.edu
Akhil SureshDept of Pharmaceutics, Manipal College of Pharmaceutical SciencesVerified email at learner.manipal.edu
Bharath Harohalli ByregowdaResearch Scholar, Manipal College of Pharmaceutical Sciences, Manipal.Verified email at learner.manipal.edu
Dr K B HarikumarRajiv Gandhi Centre for Biotechnology (RGCB)Verified email at rgcb.res.in
K Sreedhara Ranganath PaiProfessor of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal University, ManipalVerified email at manipal.edu

Krishnaprasad Baby

Research Scholar, Manipal College of Pharmaceutical Sciences

Verified email at learner.manipal.edu

Drug Design Cancer Research Repurposing


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Targeting SARS-CoV-2 main protease: a computational drug repurposing study K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak Archives of medical research 52 (1), 38-47, 2021	58	2021
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19 K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak F1000Research 9, 2020	54	2020
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak European Journal of Pharmacology 896, 173922, 2021	42	2021
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19, F1000Research, 2020, 9, 1166 K Baby, S Maity, CH Mehta, A Suresh, UY Nayak, Y Nayak This article is licensed under a Creative Commons Attribution-NonCommercial 3, 0	7
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis NN Dsouza, V Alampady, K Baby, S Maity, BH Byregowda, Y Nayak Inflammopharmacology 31 (3), 1167-1182, 2023	6	2023
In silico drug repurposing of penicillins to target main protease mpro of SARS-CoV-2 B Krishnaprasad, S Maity, C Mehta, A Suresh, UY Nayak, Y Nayak Pharmaceutical Sciences 26 (Covid-19), S52-S62, 2020	6	2020
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer K Baby, S Maity, CH Mehta, UY Nayak, GG Shenoy, KSR Pai, ... Scientific Reports 13 (1), 7947, 2023	4	2023
Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review BK Chagaleti, K Baby, SI Peña-Corona, G Leyva-Gómez, S SM, ... Naunyn-Schmiedeberg's Archives of Pharmacology, 1-15, 2024		2024
Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis BH Byregowda, K Baby, S Maity, UY Nayak, SM Fayaz, Y Nayak F1000Research 13, 216, 2024		2024

The system can't perform the operation now. Try again later.

Articles 1–9

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors